Cargando…
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
The aims were to compare the efficacy and tolerability of a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) versus placebo and to investigate the long-term tolerability of BP-C1 in the treatment of patients with metastatic breast cancer. MATERIAL AND METHO...
Autores principales: | Larsen, Stig, Butthongkomvong, Kritiya, Manikhas, Alexey, Trishkina, Ekaterina, Poddubuskaya, Elena, Matrosova, Marina, Srimuninnimit, Vichien, Lindkær-Jensen, Steen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251531/ https://www.ncbi.nlm.nih.gov/pubmed/25473312 http://dx.doi.org/10.2147/BCTT.S71781 |
Ejemplares similares
-
Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study
por: Butthongkomvong, Kritiya, et al.
Publicado: (2019) -
Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance
por: Lindkær-Jensen, Steen, et al.
Publicado: (2015) -
Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
por: Lee, Dae Ho, et al.
Publicado: (2015) -
Benzene-Poly-Carboxylic Acid Complex, a Novel Anti-Cancer Agent Induces Apoptosis in Human Breast Cancer Cells
por: Fares, Fuad, et al.
Publicado: (2014) -
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
Publicado: (2015)